Author:
Onozawa Mizuki,Akaza Hideyuki
Reference21 articles.
1. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293–7.
2. Akakura K, Isaka S, Fuse H, Akimoto S, Imai K, Yamanaka H, et al. Trends in patterns of care for prostatic cancer in Japan: statistics of 9 institutions for 5 years. Hinyokika kiyo Acta urologica Japonica. 1988;34:123–9.
3. Fujimoto H, Nakanishi H, Miki T, Kubota Y, Takahashi S, Suzuki K, et al. Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA. Int J Urol. 2011;18:876–81.
4. Cancer Registration Committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol. 2005;12:46–61.
5. Akaza H, Usami M, Hinotsu S, Ogawa O, Kagawa S, Kitamura T, et al. Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn J Clin Oncol. 2004;34:329–36.